124 related articles for article (PubMed ID: 2173612)
1. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia.
Croft KD; Beilin LJ; Vandongen R; Rouse I; Masarei J
Atherosclerosis; 1990 Aug; 83(2-3):101-9. PubMed ID: 2173612
[TBL] [Abstract][Full Text] [Related]
2. Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia.
Croft KD; Beilin LJ
Thromb Res; 1993 Feb; 69(4):333-42. PubMed ID: 8385810
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
[TBL] [Abstract][Full Text] [Related]
4. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
[TBL] [Abstract][Full Text] [Related]
5. Calcium ionophore potentiates chemotactic peptide and platelet activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
Tanizawa H; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):45-9. PubMed ID: 2169061
[TBL] [Abstract][Full Text] [Related]
6. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
8. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Ostermann G; Block HU; Till U
Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
Gentry PA; Niemuller C; Ross ML; Liptrap RM
Comp Biochem Physiol A Comp Physiol; 1989; 94(1):47-51. PubMed ID: 2571453
[TBL] [Abstract][Full Text] [Related]
10. Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis.
Laffi G; Carloni V; Baldi E; Rossi ME; Azzari C; Gresele P; Marra F; Gentilini P
Gastroenterology; 1993 Jul; 105(1):170-7. PubMed ID: 8390378
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
[TBL] [Abstract][Full Text] [Related]
12. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Ostermann G; Till U; Thielmann K
Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
[TBL] [Abstract][Full Text] [Related]
13. Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
Tanizawa H; Tai HH
Biochem Pharmacol; 1989 Aug; 38(15):2559-63. PubMed ID: 2547385
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet sensitivity and thromboxane B2 formation in type-II hyperlipoproteinaemic patients.
Tremoli E; Maderna P; Colli S; Morazzoni G; Sirtori M; Sirtori CR
Eur J Clin Invest; 1984 Oct; 14(5):329-33. PubMed ID: 6437830
[TBL] [Abstract][Full Text] [Related]
15. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Nidorf SM; Sturm M; Strophair J; Kendrew PJ; Taylor RR
Cardiovasc Res; 1989 Apr; 23(4):273-8. PubMed ID: 2590911
[TBL] [Abstract][Full Text] [Related]
16. The effect of lipoproteins on the release of some eicosanoids by stimulated human leukocytes. A possible role in atherogenesis.
Croft KD; Proudfoot J; Moulton C; Beilin LJ
Eicosanoids; 1991; 4(2):75-81. PubMed ID: 1654959
[TBL] [Abstract][Full Text] [Related]
17. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
Sugiura T; Fukuda T; Masuzawa Y; Waku K
Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
